Company Filing History:
Years Active: 2005-2009
Title: **Patricia S. Miyake: Innovator in Pharmaceutical Crystallization**
Introduction
Patricia S. Miyake is a distinguished inventor based in Tower Lakes, Illinois, known for her significant contributions to the field of pharmaceuticals through her innovative work in crystalline forms of therapeutic compounds. With a total of two patents to her name, her inventions have focused on improving the solubility and bioavailability of essential drugs.
Latest Patents
Miyake's latest patents encompass advanced pharmaceutical compositions that enhance the delivery and efficacy of selective cyclooxygenase-2 inhibitors. One of her notable inventions involves polymorphic crystalline forms of celecoxib. These compositions include one or more orally deliverable dose units that consist of solid particles of celecoxib, with a weight percentage ranging from 25% to 100% smaller than one micrometer. This innovative form provides a rapid therapeutic effect, particularly beneficial for conditions requiring quick pain relief.
Additionally, she has developed crystalline forms of the p38 kinase inhibitor, specifically N-(2-hydroxyacetyl)-5-(4-piperidyl)-4-(4-pyrimidinyl)-3-(4-chlorophenyl)pyrazole. Her work here includes several anhydrous and solvated forms that display enhanced stability and unique properties compared to previous solid-state arrangements. These advancements are promising for the treatment of p38 kinase-mediated conditions, offering new avenues for effective pharmaceutical therapy.
Career Highlights
Over the years, Patricia S. Miyake has worked with industry giants such as Pfizer Corporation and Pharmacia Corporation. Her expertise in pharmaceutical science and crystallization has propelled her career forward, allowing her to contribute to the development of innovative drug formulations that enhance therapeutic outcomes.
Collaborations
Throughout her career, Miyake has collaborated with notable professionals in her field. Among her coworkers are Leonard J. Ferro and Kimberley C. Allen, who have also contributed to the advancements in pharmaceutical sciences. Their joint efforts have played an essential role in bringing forward innovative solutions in drug development.
Conclusion
In conclusion, Patricia S. Miyake's contributions to the pharmaceutical industry, particularly in crystalline forms of drugs, underscore her role as a leading inventor in her field. With her patents focusing on enhancing drug delivery and efficacy, she continues to drive forward innovations that hold significant promise for improving patient treatments and outcomes.